Physician

Tammy H Young, M.D.

According to 2025 Medicare claims, Tammy Young, M.D. (NPI: 1013911668) practices hematology/oncology in the Jackson, MS market, with the plurality of this provider's patient population coming from Madison, MS. This provider's primary affiliated billing organization is JACKSON ONCOLOGY ASSOCIATES (NPI: 1295776136; TIN: 640619700) and primary practice location at 39202-2002. Young is affiliated with the Health Leaders Network of Mississippi LLC (ACO ID: A5148), CoreHealth Alliance LLC (ACO ID: A5645), and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Young's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,506 traditional Medicare patients, billed 464,459 HCPCS/CPT codes, and received $10,961,718 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,080 prescription claims across 763 beneficiaries totaling $9,737,732 in drug costs, led by Verzenio (Abemaciclib). DME data shows 268 claims. Open Payments data shows 81 records totaling $3,670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,883,211 to $10,961,718. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,077,449 to $9,737,732. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,143 and ending at $35,868.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,134	291,242	$3,883,211
2016	1,068	345,219	$5,462,817
2017	1,161	385,739	$5,753,437
2018	1,391	472,545	$6,676,380
2019	1,399	432,058	$6,362,002
2020	1,268	483,203	$8,028,553
2021	1,386	523,770	$8,615,771
2022	1,353	515,134	$9,016,477
2023	1,441	472,560	$9,116,857
2024	1,506	464,459	$10,961,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	623	6,311	$3,077,449
2016	623	6,746	$3,664,100
2017	673	6,867	$2,960,806
2018	712	7,111	$4,684,876
2019	734	6,275	$5,762,249
2020	711	5,868	$6,488,886
2021	687	5,081	$6,854,581
2022	702	5,055	$10,347,057
2023	711	4,478	$8,675,970
2024	763	5,080	$9,737,732

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	156	525	$139,599
2016	128	321	$81,956
2017	102	264	$70,554
2018	86	179	$26,051
2019	84	242	$27,254
2020	100	296	$25,514
2021	113	302	$24,507
2022	83	218	$13,370
2023	109	279	$39,926
2024	93	268	$18,278

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,118	2,717	$90
86300	Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3	635	1,461	$20
80053	Blood test, comprehensive group of blood chemicals	1,292	4,322	$10
36415	Insertion of needle into vein for collection of blood sample	1,182	3,643	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,300	4,614	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	111	3,102	$1,657,405
Imbruvica	Ibrutinib	83	2,334	$1,315,685
Revlimid	Lenalidomide	73	1,862	$1,152,649
Tagrisso	Osimertinib Mesylate	53	1,590	$906,713
Ibrance	Palbociclib	51	1,428	$779,770

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8030	Breast prosthesis, silicone or equal, without integral adhesive	N	16	16	$5,916
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	27	33	$4,180
J8521	Capecitabine, oral, 500 mg	N	19	73	$2,882
A4419	Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each	N	N/R	12	$1,326
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	24	$1,190

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$2,105	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,566	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tammy H. Young, M.D.?

Tedicare shows public-source Medicare data for Tammy H. Young, M.D. (NPI 1013911668), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tammy H. Young, M.D. have ACO affiliation data?

Tammy H. Young, M.D. is shown with ACO affiliation data for Health Leaders Network of Mississippi LLC (MSSP, ACO ID A5148), CoreHealth Alliance LLC (MSSP, ACO ID A5645), and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Tammy H. Young, M.D.?

Tammy H. Young, M.D. is linked to JACKSON ONCOLOGY ASSOCIATES (billing NPI 1295776136) in the available physician profile data.

Does Tammy H. Young, M.D. have Open Payments data?

Tammy H. Young, M.D. has 81 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.